A 57-year-old man with a benign medical history developed diplopia with left gaze for over a month prior to presentation. A neurological examination revealed signs of right oculomotor paresis, including ptosis; exotropia; anisocoria (the right pupillary size was fixed at 3.5 mm, while the left one was 2 mm in light and 4 mm in dark); and impaired adduction, elevation, and depression of the right eye ([Picture A](#g001){ref-type="fig"}). No trigeminal nerve disorders were observed. Brain magnetic resonance imaging (MRI) showed a parasellar tumor extending into the right cavernous sinus ([Picture B](#g001){ref-type="fig"}). Blood tests revealed elevated prostate-specific antigen (129 ng/mL, normal \<4 ng/mL) and alkaline phosphatase (1,207 IU/L, normal \<338 IU/L) levels. Bone scintigraphy showed multiple osteoblastic lesions in the skull base, thoracolumbar spine and pelvis ([Picture C](#g001){ref-type="fig"}). Prostate needle biopsy revealed prostate adenocarcinoma ([Picture D](#g001){ref-type="fig"}). The findings suggested right oculomotor paresis secondary to metastatic prostate cancer. Monthly injections of a gonadotropin-releasing-hormone antagonist, degarelix, were administered (240 mg initially, 80 mg/month thereafter). His symptoms resolved two days after the first injection, with no evidence of relapse 7 months later. Follow-up MRI revealed the near-absence of the parasellar tumor. Clinicians should consider ophthalmoplegia as a rare initial presentation of cavernous sinus lesions in patients with metastatic prostate adenocarcinoma ([@B1],[@B2]).
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